載入...
Application of PBPK Modeling and Virtual Clinical Study Approaches to Predict the Outcomes of CYP2D6 Genotype‐Guided Dosing of Tamoxifen
The Tamoxifen Response by CYP2D6 Genotype‐based Treatment‐1 (TARGET‐1) study (n = 180) was conducted from 2012–2017 in Japan to determine the efficacy of tamoxifen dosing guided by cytochrome P450 2D6 (CYP2D6) genotypes. To predict its outcomes prior to completion, we constructed the comprehensive p...
Na minha lista:
發表在: | CPT Pharmacometrics Syst Pharmacol |
---|---|
Main Authors: | , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
John Wiley and Sons Inc.
2018
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6063740/ https://ncbi.nlm.nih.gov/pubmed/29920987 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/psp4.12307 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|